Medical Journals In Leukaemia
The
cancer of blood and bone marrow is called . The blood
cells are produced by the bone marrow. The problem in the development of the red blood
cells leads to the development of Leukemia. It typically affects the leukocytes, or white blood cells. Leukemia is most likely to affect people over the age of 55 years and is also most commonly observed in those aged under 15 years. There are numerous diverse types of
leukemia and the best course of treatment and action can be taken based on the type and stage of the disease. When the DNA of developing blood cells, mainly white cells, incurs damage Leukemia develops and this leads the blood
cells to grow and divide uncontrollably.
High Impact List of Articles
-
Hearing loss in systemic sclerosis - clinically important, potentially treatable and often overlooked
Tamer A. Gheita and Hanan M Fathi
Editorial: International Journal of Clinical Rheumatology
-
Hearing loss in systemic sclerosis - clinically important, potentially treatable and often overlooked
Tamer A. Gheita and Hanan M Fathi
Editorial: International Journal of Clinical Rheumatology
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Prospective: Clinical Investigation
-
Drug-eluting stents and glycoprotein IIbIIIa inhibitors in the pharmacoinvasive management of ST elevation MI
JP Leitner & JD Abbott
Short Article: Interventional Cardiology
-
Drug-eluting stents and glycoprotein IIbIIIa inhibitors in the pharmacoinvasive management of ST elevation MI
JP Leitner & JD Abbott
Short Article: Interventional Cardiology
-
Treatment of the elderly rheumatoid arthritis patient
Daniel E Furst
Special Issue Article: International Journal of Clinical Rheumatology
-
Treatment of the elderly rheumatoid arthritis patient
Daniel E Furst
Special Issue Article: International Journal of Clinical Rheumatology
Relevant Topics in Clinical